Enhanced recovery after surgery (ERAS) program for patients with peritoneal surface malignancies undergoing cytoreductive surgery with or without HIPEC: a …

M Robella, M Tonello, P Berchialla, V Sciannameo… - Cancers, 2023 - mdpi.com
Simple Summary Cytoreductive surgery and Hyperthermic IntraPEritoneal Chemotherapy
(HIPEC) represent a promising treatment strategy for the management of selected cases of …

[HTML][HTML] Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery …

M Hübner, S Kusamura, L Villeneuve… - European Journal of …, 2020 - Elsevier
Background Enhanced recovery after surgery (ERAS) pathways have been shown to
considerably reduce complications, length of stay and costs after most of surgical …

Enhanced recovery after surgery for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a systematic review and meta …

F Mao, Z Huang - Frontiers in Surgery, 2021 - frontiersin.org
Background: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) is a promising approach for the management of peritoneal carcinomatosis, but is …

Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic …

SL Solanki, S Mukherjee, V Agarwal… - Indian Journal of …, 2019 - journals.lww.com
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for
primary peritoneal malignancies or peritoneal spread of malignant neoplasm is being done …

Impact of successful implementation of an Enhanced Recovery After Surgery protocol for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal …

BJ Sun, TM Yue, N Xu, C Fowler, B Lee - Annals of Surgical Oncology, 2023 - Springer
Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
(CRS/HIPEC) are complex operations for the treatment of peritoneal metastases. Enhanced …

Impact of enhanced recovery after surgery on postoperative outcomes for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

B White, F Dahdaleh, SA Naffouje, N Kothari… - Annals of Surgical …, 2021 - Springer
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) have been associated with significant morbidity and increased hospital length of …

Cost analysis and financial implications of a peritoneal surface malignancy program in the USA

AA Abreu, E Farah, R Nix, D Kethley, C Coble… - Annals of Surgical …, 2024 - Springer
Background We aimed to describe the financial implications of cytoreductive surgery and
hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in the USA. Materials and …

Cytoreductive surgery and HIPEC in an enhanced recovery after surgery program: a feasibility study

PW Lu, AC Fields, G Shabat, R Bleday… - Journal of Surgical …, 2020 - Elsevier
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy
(HIPEC) have historically been associated with high morbidity given the physiologic insult of …

Adoption of an enhanced recovery after surgery protocol increases cost of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and does not improve …

Y Ciftci, SN Radomski, BA Johnson… - Annals of surgical …, 2024 - Springer
Background Enhanced recovery after surgery (ERAS) protocols have been shown to reduce
length of stay (LOS) and complications. The impact of ERAS protocols on the cost of …

Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey

G Bhandoria, SL Solanki, M Bhavsar… - Pleura and …, 2021 - degruyter.com
Objectives Enhanced recovery after surgery (ERAS) protocols have been questioned in
patients undergoing cytoreductive surgery (CRS) with/without hyperthermic intraperitoneal …